HEALWELL, in collaboration with Takeda Pharmaceutical, presented new AI generated and regulatory-grade real-world data (RWD) on vedolizumab dose escalation in ulcerative colitis and Crohn's disease at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback